Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
HESKA CORP (HSKA) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/05/2023 8-K Quarterly results
Docs: "Heska Corporation Reports First Quarter 2023 Results"
02/28/2023 8-K Quarterly results
Docs: "Heska Corporation Reports Fourth Quarter and Full Year 2022 Results"
11/08/2022 8-K Quarterly results
08/08/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
02/28/2022 8-K Quarterly results
11/04/2021 8-K Quarterly results
Docs: "Heska Corporation Reports Third Quarter 2021 Results"
08/03/2021 8-K Quarterly results
05/06/2021 8-K Quarterly results
02/23/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "Heska Corporation Reports Third Quarter 2020 Results"
08/04/2020 8-K Quarterly results
05/07/2020 8-K Quarterly results
02/25/2020 8-K Quarterly results
11/05/2019 8-K Quarterly results
Docs: "Heska Corporation Reports Third Quarter 2019 Results Revenue $31.2 Million, Diagnostic Consumables Sales up 20.9% New Product Launches and Core Business Growth Initiatives Reiterated LOVELAND, CO, November 5, 2019 -- Heska Corporation , a provider of advanced veterinary diagnostic and specialty healthcare products, today reported financial results for its third quarter ended September 30, 2019. The Company reports results in two segments: Core Companion Animal and Other Vaccines and Pharmaceuticals . Point of Care is referred to in this release as “POC”. The Company forecast for 2019 from the February 26, 2019 earnings call and release is referred to in this release as “Outlook”. 2019 Third Quarter and Year Over Year Metrics $ in Millions except Earnings Per Share Q3 Q3 YOY Consolidated Re..."
08/06/2019 8-K Quarterly results
05/07/2019 8-K Quarterly results
Docs: "Heska Reports First Quarter 2019 Results Revenue $29.5 Million, Margins Solid, Multi-Year Highs in Subscriptions Gains Management Reiterates Full Year Outlook, New Product Launches and Core Business Growth Initiatives LOVELAND, CO, May 7, 2019 -- Heska Corporation , a provider of advanced veterinary diagnostic and specialty healthcare products, today reported financial results for its first quarter ended March 31, 2019. The Company reports results in two segments: Core Companion Animal and Other Vaccines and Pharmaceuticals . Point of Care is referred to in this release as “POC”. The Company forecast for 2019 from the February 26, 2019 earnings call and release is referred to in this release as "Outlook". 2019 First Quarter, Year Over Year , and Full Year Outlook Metrics $ in Millions exce..."
02/26/2019 8-K Quarterly results
11/06/2018 8-K Quarterly results
Docs: "Heska Reports Third Quarter Results Revenue $31.0 million Diagnostic Consumables Sales up 19.3%"
08/07/2018 8-K Quarterly results
Docs: "Heska Reports Second Quarter Results Revenue $29.7 million; Earnings per Diluted Share $0.24 Diagnostic Consumables up 16%"
05/04/2018 8-K Quarterly results
Docs: "Heska Reports First Quarter Results Revenue up 11%, Diagnostic Consumables up 17%, Raises Sales Outlook LOVELAND, CO, May 4, 2018 -- Heska Corporation , a provider of advanced veterinary diagnostic and specialty products, today reported financial results for its first quarter ended March 31, 2018. First Quarter 2018 Highlights with Prior Year Comparison:"
02/28/2018 8-K Quarterly results
Docs: "Heska Reports Fourth Quarter and Full Year 2017 Results Sets Analyst Day for May 15, 2018 in New York City to Discuss New Products and Initiatives LOVELAND, CO, February 28, 2018 -- Heska Corporation , a provider of advanced veterinary diagnostic and specialty products, today reported financial results for its fourth quarter and year ended December 31, 2017. The Company is recording a non-recurring, non-cash accounting charge of $5.9 million related to enactment of the 2017 Tax Cuts and Jobs Act for the revaluation of deferred tax assets and valuation allowance, primarily consisting of Heska's net operating loss carry-forwards in light of the new 2017 Tax Cuts and Jobs Act tax rate of 21%. Fourth Quarter and FY 2017 results with Prior Year Comparison:"
11/02/2017 8-K Quarterly results
Docs: "Heska Reports Third Quarter Results"
05/02/2017 8-K Form 8-K - Current report
11/01/2016 8-K Form 8-K - Current report
08/03/2016 8-K Form 8-K - Current report
05/03/2016 8-K Quarterly results
Docs: "Heska Reports Record First Quarter Results Revenue Up 19%; Earnings Per Share of $0.17, up 98% over Q1 2015"
03/03/2016 8-K Form 8-K - Current report
11/12/2015 8-K Quarterly results
Docs: "Heska Income Up 176% to 20 cents per diluted share in the Third Quarter of 2015 and Revenues up 29% LOVELAND, CO, November 11, 2015 -- Heska Corporation , a provider of advanced veterinary diagnostic and specialty products, today reported financial results for its third quarter ended September 30, 2015. Third Quarter 2015 Highlights with Prior Year Comparison:"
07/29/2015 8-K Quarterly results
Docs: "Heska Reports Financial Results for the Second Quarter of 2015"
05/07/2015 8-K Quarterly results
Docs: "Heska Reports 10% Revenue Growth, $0.09 Per Share for the First Quarter of 2015"
03/05/2015 8-K Quarterly results
Docs: "Heska Reports Full-Year Revenue Growth and $0.41 Per Share"
10/29/2014 8-K Quarterly results
Docs: "Heska Reports 24% Revenue Growth, $0.08 Per Share for the Third Quarter of 2014"
07/30/2014 8-K Quarterly results
Docs: "Heska Reports 25.5% Revenue Growth, $0.17 Per Share vs. $, for the Second Quarter of 2014"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy